Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
19 May 2026
IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story
COPD exacerbations place a considerable burden on patients and healthcare systems.1-3 Even with optimised maintenance therapy, many…
27 Apr 2026
Erratum: Natural History of a Giant Bladder Stone
2
Mins
27 Apr 2026
Factors Associated with Inferior Outcomes in Patients with Advanced Urothelial Carcinoma
Enfortumab vedotin plus pembrolizumab (EV+P) is the preferred first-line (1L) regimen for patients with advanced urothelial carcinoma…
20 Apr 2026
An FDA Approval for Certain Patients with Endometrial Cancer
16 Apr 2026
HRD Testing in Ovarian Cancer
Clinical practice pearls on HRD testing workflows and reporting nuances that may shape downstream decisions…
27 Mar 2026
Ultrasound in Aesthetics
Join Dermatology and expert trainer Chris Dewsbury for an interactive webinar exploring how ultrasound and the GE Vscan are enhancing…
10
Mins
25 Mar 2026
Review of the European Association for Haemophilia and Allied Disorders (EAHAD) 19th Annual Congress
IN the vibrant city of Dublin, Ireland, over 2,000 delegates from over 77 countries gathered for the 19th annual European Association for…
25 Mar 2026
The History of Von Willebrand Disease
The first case of VWD was described and published in 1926 by Erik von Willebrand. Therefore, 2026 marks its centenary anniversary…
5
Mins
25 Mar 2026
Von Willebrand Disease: 100 Years of Progress and New Horizons
The 2026 Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) placed special emphasis on the centenary…
8
Mins
25 Mar 2026
EAHAD 2026 Interview: Ana Boban
We had the pleasure of speaking with Ana Boban, President of the European Association for Haemophilia and Allied Disorders…
1
2
3
4
…
193
194
195
→
We’ve noticed you’re accessing
from
North/South America.
View
View